HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Short term Debt (2015 - 2026)

HUTCHMED (China)'s (HMDCF) quarterly Short term Debt came in at $22.4 million in Q2 2026, down 12.49% year-over-year from $25.6 million in Q2 2025, and down 10.27% quarter-over-quarter from $25.0 million in Q4 2025.

Analysis

HUTCHMED (China) (HMDCF) Short term Debt (2015 - 2026) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Short term Debt for 12 consecutive years, with $22.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Short term Debt fell 12.49% year-over-year to $22.4 million in Q2 2026; TTM through Jun 2026 was $22.4 million, a 12.49% decrease from a year earlier, with the FY2025 full-year figure at $25.0 million, down 69.84% from the prior year.
  • Short term Debt was $22.4 million for Q2 2026 at HUTCHMED (China), down from $25.0 million in the prior quarter.
  • Over five years, Short term Debt peaked at $82.8 million in Q4 2024 and troughed at $18.1 million in Q4 2022.
  • A 5-year average of $40.0 million and a median of $25.6 million in 2025 frame the typical range for Short term Debt.
  • Across the five-year window, Short term Debt soared 338.27% in 2023 and sank 69.84% in 2025, its largest moves.
  • Over 5 years, Short term Debt stood at $18.1 million in 2022, then soared by 338.27% to $79.3 million in 2023, then advanced by 4.36% to $82.8 million in 2024, then slumped by 69.84% to $25.0 million in 2025, then declined by 10.27% to $22.4 million in 2026.
  • The last three Short term Debt figures came in at $22.4 million (Q2 2026), $25.0 million (Q4 2025), and $25.6 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.51 Bn 197.52 Bn 7.24 Bn
2 Gilead Sciences 181.48 Bn 178.30 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.45 Bn 124.60 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.87 Bn 74.88 Bn 3.93 Bn
5 Argenx Se 61.59 Bn 56.41 Bn 1.37 Bn
6 Moderna 54.72 Bn 49.59 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.13 Bn 30.82 Bn 992.69 Mn
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn
9 Roivant Sciences 30.31 Bn 30.31 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.41 Mn
Dec 31, 2025 24.97 Mn
Jun 30, 2025 25.60 Mn
Dec 31, 2024 82.81 Mn
Jun 30, 2024 26.47 Mn
Dec 31, 2023 79.34 Mn
Dec 31, 2022 18.10 Mn
Dec 31, 2021 26.91 Mn
Jun 30, 2021 26.88 Mn
Dec 31, 2020 26.86 Mn
Sep 30, 2019 1.50 Mn
Jun 30, 2019 2.80 Mn
Mar 31, 2019 7.42 Mn
Dec 31, 2018 6.51 Mn
Dec 31, 2017 1.55 Mn
Jun 30, 2017 5.40 Mn
Dec 31, 2016 19.96 Mn
Dec 31, 2015 23.08 Mn